EMA recommends first COVID-19 vaccine for authorisation in the EU: EMA has recommended granting a
conditional marketing authorisation for the vaccine
Comirnaty,
developed by BioNTech and Pfizer, to prevent coronavirus disease 2019
(COVID-19) in people from 16 years of age. EMA’s scientific opinion
paves the way for the first
marketing authorisation of a COVID-19 vaccine in the EU by the European Commission, with all the safeguards, controls and obligations this entails.
